Area of research
Hematology · Genetics
Research interest
Research interests include Medicine, Internal medicine, Imatinib, Hazard ratio, Cohort, and Thrombocytosis.
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale
A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
Molecular diagnosis of the myeloproliferative neoplasms: <scp>UK</scp> guidelines for the detection of <i><scp>JAK</scp>2 </i><scp>V</scp>617<scp>F</scp> and other relevant mutations